NSCLC NCI-H292 and NCI-H460 cells were treated with recombinant human IL-6 or neutralizing antibody (IL-6 Ab), and their effects on cell migration and invasion were examined using Transwell assays (Fig. 5A; Additional file 2: Fig. S12). Here, IL6 is linked to non-small cell lung carcinoma.